GURUFOCUS.COM » STOCK LIST » Healthcare » Drug Manufacturers » Choong Ang Vaccine Laboratory Co Ltd (XKRX:072020) » Definitions » EBIT

Choong Ang Vaccine Laboratory Co (XKRX:072020) EBIT : ₩7,696 Mil (TTM As of Mar. 2024)


View and export this data going back to 2003. Start your Free Trial

What is Choong Ang Vaccine Laboratory Co EBIT?

Choong Ang Vaccine Laboratory Co's earnings before interest and taxes (EBIT) for the three months ended in Mar. 2024 was ₩2,146 Mil. Its earnings before interest and taxes (EBIT) for the trailing twelve months (TTM) ended in Mar. 2024 was ₩7,696 Mil.

EBIT or Operating Income is linked to Return on Capital for both regular definition and Joel Greenblatt's definition. Choong Ang Vaccine Laboratory Co's annualized ROC % for the quarter that ended in Mar. 2024 was 5.25%. Choong Ang Vaccine Laboratory Co's annualized ROC (Joel Greenblatt) % for the quarter that ended in Mar. 2024 was 11.08%.

EBIT is also linked to Joel Greenblatt's definition of earnings yield. Choong Ang Vaccine Laboratory Co's Earnings Yield (Joel Greenblatt) % for the quarter that ended in Mar. 2024 was 9.11%.


Choong Ang Vaccine Laboratory Co EBIT Historical Data

The historical data trend for Choong Ang Vaccine Laboratory Co's EBIT can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Choong Ang Vaccine Laboratory Co EBIT Chart

Choong Ang Vaccine Laboratory Co Annual Data
Trend Dec14 Dec15 Dec16 Dec17 Dec18 Dec19 Dec20 Dec21 Dec22 Dec23
EBIT
Get a 7-Day Free Trial Premium Member Only Premium Member Only 2,212.37 3,407.43 6,510.63 5,048.93 7,824.51

Choong Ang Vaccine Laboratory Co Quarterly Data
Jun19 Sep19 Dec19 Mar20 Jun20 Sep20 Dec20 Mar21 Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24
EBIT Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 2,275.29 844.69 1,725.30 2,979.24 2,146.28

Competitive Comparison of Choong Ang Vaccine Laboratory Co's EBIT

For the Drug Manufacturers - Specialty & Generic subindustry, Choong Ang Vaccine Laboratory Co's EV-to-EBIT, along with its competitors' market caps and EV-to-EBIT data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


Choong Ang Vaccine Laboratory Co's EV-to-EBIT Distribution in the Drug Manufacturers Industry

For the Drug Manufacturers industry and Healthcare sector, Choong Ang Vaccine Laboratory Co's EV-to-EBIT distribution charts can be found below:

* The bar in red indicates where Choong Ang Vaccine Laboratory Co's EV-to-EBIT falls into.



Choong Ang Vaccine Laboratory Co EBIT Calculation

EBIT, sometimes also called Earnings Before Interest and Taxes, is a measure of a firm's profit that includes all expenses except interest and income tax expenses. It is the difference between operating revenues and operating expenses. When a firm does not have non-operating income, then Operating Income is sometimes used as a synonym for EBIT and operating profit.

EBIT for the trailing twelve months (TTM) ended in Mar. 2024 adds up the quarterly data reported by the company within the most recent 12 months, which was ₩7,696 Mil.

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.


Choong Ang Vaccine Laboratory Co  (XKRX:072020) EBIT Explanation

1. EBIT or Operating Income is linked to Return on Capital for both regular definition and Joel Greenblatt's definition.

Choong Ang Vaccine Laboratory Co's annualized ROC % for the quarter that ended in Mar. 2024 is calculated as:

ROC % (Q: Mar. 2024 )
=NOPAT/Average Invested Capital
=Operating Income * ( 1 - Tax Rate % )/( (Invested Capital (Q: Dec. 2023 ) + Invested Capital (Q: Mar. 2024 ))/ count )
=5793.78 * ( 1 - 20.13% )/( (89556.156 + 86710.586)/ 2 )
=4627.492086/88133.371
=5.25 %

where

Invested Capital(Q: Dec. 2023 )
=Total Assets - Accounts Payable & Accrued Expense - Excess Cash
=Total Assets - Accounts Payable & Accrued Expense - ( Cash, Cash Equivalents, Marketable Securities - max(0, Total Current Liabilities - Total Current Assets+Cash, Cash Equivalents, Marketable Securities))
=119592.514 - 2612.182 - ( 27424.176 - max(0, 12652.855 - 50561.011+27424.176))
=89556.156

Invested Capital(Q: Mar. 2024 )
=Total Assets - Accounts Payable & Accrued Expense - Excess Cash
=Total Assets - Accounts Payable & Accrued Expense - ( Cash, Cash Equivalents, Marketable Securities - max(0, Total Current Liabilities - Total Current Assets+Cash, Cash Equivalents, Marketable Securities))
=117341.046 - 4194.95 - ( 26435.51 - max(0, 11218.132 - 49200.693+26435.51))
=86710.586

Note: The Operating Income data used here is four times the quarterly (Mar. 2024) data.

2. Joel Greenblatt's definition of Return on Capital:

Choong Ang Vaccine Laboratory Co's annualized ROC (Joel Greenblatt) % for the quarter that ended in Mar. 2024 is calculated as:

ROC (Joel Greenblatt) %(Q: Mar. 2024 )
=EBIT/Average of (Net fixed Assets + Net Working Capital)
=EBIT/Average of (Property, Plant and Equipment+Net Working Capital)
     Q: Dec. 2023  Q: Mar. 2024
=EBIT/( ( (Property, Plant and Equipment + Net Working Capital) + (Property, Plant and Equipment + Net Working Capital) )/ count )
=8585.132/( ( (63271.634 + max(14429.64, 0)) + (63487.107 + max(13796.962, 0)) )/ 2 )
=8585.132/( ( 77701.274 + 77284.069 )/ 2 )
=8585.132/77492.6715
=11.08 %

where Working Capital is:

Working Capital(Q: Dec. 2023 )
=(Accounts Receivable + Total Inventories + Other Current Assets) - (Accounts Payable & Accrued Expense + Defer. Rev. + Other Current Liabilities)
=(4193.144 + 18463.601 + 171.155) - (2612.182 + 0 + 5786.078)
=14429.64

Working Capital(Q: Mar. 2024 )
=(Accounts Receivable + Total Inventories + Other Current Assets) - (Accounts Payable & Accrued Expense + Defer. Rev. + Other Current Liabilities)
=(3845.779 + 18743.848 + 175.556) - (4194.95 + 0 + 4773.271)
=13796.962

When net working capital is negative, 0 is used.

Note: The EBIT data used here is four times the quarterly (Mar. 2024) EBIT data.

3. It is also linked to Joel Greenblatt's definition of Earnings Yield:

Choong Ang Vaccine Laboratory Co's Earnings Yield (Joel Greenblatt) % for today is calculated as:

Earnings Yield (Joel Greenblatt) %=EBIT (TTM)/Enterprise Value (Q: Mar. 2024 )
=7695.51/84440.108
=9.11 %

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.


Choong Ang Vaccine Laboratory Co EBIT Related Terms

Thank you for viewing the detailed overview of Choong Ang Vaccine Laboratory Co's EBIT provided by GuruFocus.com. Please click on the following links to see related term pages.


Choong Ang Vaccine Laboratory Co (XKRX:072020) Business Description

Traded in Other Exchanges
N/A
Address
1476-37 Yongsan-dong, Yuseong-gu, Daejeon, KOR, 305-348
Choong Ang Vaccine Laboratory Co., Ltd. manufactures and markets vaccines for animals. The company specialized in vaccines for animals and is the largest one in Korea. The company has a solid financial structure.

Choong Ang Vaccine Laboratory Co (XKRX:072020) Headlines

No Headlines